Chiesi to buy KalVista in $1.9B deal for rare disease drug
Chiesi to buy KalVista in $1.9B deal for rare disease drug
المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.
Chiesi to buy KalVista in $1.9B deal for rare disease drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.